Table 3. Tumor Response and Clinical Situation at the Time of the Tumor Response Assessment Protocol Termination in 127 Patients.
| Tumor Response Overall | CR | PR | SD | Non-PD | PD | |||
|---|---|---|---|---|---|---|---|---|
| All | 127 | 9 (7.1) | 33 (26.0) | 3 (2.4) | 45 (35.4) | 82 (64.6) | ||
| Death | 3 (2.4) | 2 (22.2) | 1 (3.0) | 3 (6.7) | ||||
| Follow-up loss or transfer | 20 (15.7) | 3 (33.3) | 8 (24.2) | 1 (33.3) | 12 (26.7) | 8 (9.8) | ||
| Other treatment | 104 (81.9) | 4 (44.4) | 24 (72.7) | 2 (66.7) | 30 (66.7) | 74 (90.2) | ||
| Conventional chemoembolization | 66 (52.0) | 1 (11.1) | 12 (36.4) | 1 (33.3) | 14 (31.1) | 52 (63.4) | ||
| + Combination treatment | 4 (3.1) | 1 (11.1) | 1 (3.0) | 2 (4.4) | 2 (2.4) | |||
| Radiofrequency ablation | 23 (18.1) | 1 (11.1) | 9 (27.3) | 10 (22.2) | 13 (15.9) | |||
| Percutaneous ethanol injection | 6 (4.7) | 2 (6.1) | 2 (4.4) | 4 (4.9) | ||||
| Liver transplantation | 4 (3.2) | 1 (11.1) | 1 (2.2) | 3 (3.7) | ||||
| Resection | 3 (2.4) | 1 (11.1) | 1 (3.0) | 1 (33.3) | 3 (6.7) | |||
| Intraarterial chemotherapy | 2 (1.6) | 2 (2.4) | ||||||
Values are number of patients with the percentage in parentheses. CR = complete response, PD = progressive disease, PR = partial response, SD = stable disease